Delta-Fly Pharma (TSE:4598) Other Current Payables: 円175.67 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4598 Delta-Fly Pharma Inc TSE:4598
30 GF Score
Price 円124.00
! 2 Warning Signs
View Full Analysis

What is Delta-Fly Pharma Other Current Payables?

Delta-Fly Pharma TSE:4598 -3.88% 30 Other Current Payables is 円175.67 Mil as of Mar. 2026. GuruFocus rates TSE:4598 with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

Delta-Fly Pharma's Other Current Payables for the quarter that ended in Mar. 2026 was 円175.67 Mil.

Delta-Fly Pharma's quarterly Other Current Payables declined from Sep. 2025 (円122.06 Mil) to Dec. 2025 (円98.27 Mil) but then increased from Dec. 2025 (円98.27 Mil) to Mar. 2026 (円175.67 Mil).

Delta-Fly Pharma's annual Other Current Payables declined from Mar. 2024 (円207.07 Mil) to Mar. 2025 (円124.59 Mil) but then increased from Mar. 2025 (円124.59 Mil) to Mar. 2026 (円175.67 Mil).

Delta-Fly Pharma Other Current Payables Related Terms

Delta-Fly Pharma Other Current Payables Historical Data

* Premium members only.

The historical data trend for Delta-Fly Pharma's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delta-Fly Pharma Other Current Payables Chart

Delta-Fly Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.34 89.87 207.07 124.59 175.67

Delta-Fly Pharma Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 124.59 120.47 122.06 98.27 175.67
TSE:4598
30GF Score
Delta-Fly Pharma Inc TSE:4598
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Delta-Fly Pharma Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of 円175.67 Mil mean?
Delta-Fly Pharma (TSE:4598) has a Other Current Payables of 円175.67 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Delta-Fly Pharma and its competitors.
Is Delta-Fly Pharma's Other Current Payables too high?
Delta-Fly Pharma's current Other Current Payables is 円175.67 Mil. Overall, Delta-Fly Pharma has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Delta-Fly Pharma's Other Current Payables compare to VRTX and REGN?
Delta-Fly Pharma's Other Current Payables of 円175.67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Delta-Fly Pharma and its competitors. Delta-Fly Pharma's current Other Current Payables is 円175.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delta-Fly Pharma stock overvalued right now?
Delta-Fly Pharma (TSE:4598) has a current Other Current Payables of 円175.67 Mil. The current Other Current Payables is 円175.67 Mil. Delta-Fly Pharma's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Delta-Fly Pharma (TSE:4598), the current Other Current Payables is 円175.67 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Delta-Fly Pharma Business Description

Address 37-5, Miyajima Nishikino, Kawauchi-cho, Tokushima, JPN, 771-0116
Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.
30GF Score

Get the complete analysis for TSE:4598

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円124.00
Price